Analytica Limited (ASX:ALT)


right-arrow Created with Sketch. 0 (0%)
MCAP $9.227M
Last trade 10.00am 21/01/2022 20mins delayed

Latest Announcements

22/12/2021ALTAnalytica Limited
22/12/2021ALTAnalytica Limited
22/12/2021ALTAnalytica Limited
25/11/2021ALTAnalytica Limited
25/11/2021ALTAnalytica Limited
25/11/2021ALTAnalytica Limited
11/11/2021ALTAnalytica Limited
09/11/2021ALTAnalytica Limited

Company Overview

Analytica Limited is a product development and commercialization company that focused on Class I and II medical device products. Analytica’s lead product is the PeriCoach system is an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal, and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to PeriCloud where physicians can monitor patient progress via the Web portal. It is also commercializing the AutoStart Burette infusion system. The AutoStart burette set automatically restarts the delivery of intravenous fluid once the burette has dispensed its predetermined amount of liquid or drug. Automatic restart of the IV fluid, once the drug is dispensed can provide enormous savings in nursing time during and following a medication event and reduces the risk of blood clots forming that may obstruct the intravenous cannula.

ALT in the news

Analytica (ALT) has entered into a joint venture agreement to manufacture, distribute…
Analytica has announced the PeriCoach system is CE-Marked to assist in the…

Search Previous Announcements